The reduced EdU incorporation, upregulated r-H2Ax level, increased cell cycle arrest in S phase and reversibility by dNTP precursors, the dose-dependent cell viability inhibition and apoptosis induction together indicated that the compound inhibited DNA synthesis and thereby cell proliferation by inhibiting RNR activity in treated AML cells. The gene discussed is H2AX; the disease is acute myeloid leukemia.